Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

Global Animal Pharmaceuticals Market to Grow at a CAGR of 7.7% by 2022 - Increasing Zoonotic & Food Borne Diseases - Research and Markets

DUBLIN, Mar 7, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Animal Pharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.

The global animal pharmaceuticals market was valued at $12,614.3 million in 2015, and it is expected to grow at a CAGR of 7.7% during 2016 - 2022. The increasing consumption of meat and milk, increasing zoonotic and food borne diseases, and increasing trend of pet adoption are the key factors driving the growth of the global market.

The evolution of new diseases in animals and emerging economies offer ample opportunities for the growth of animal pharmaceuticals market. To find enhanced solutions for prevailing and new diseases, the companies in the animal pharmaceuticals market are active in research and development activities. Evolution of new diseases in animals drives the research and development of new pharmaceuticals for the treatment of these diseases. Different companies are targeting research for the development of new drugs and to exploit market potential. However, increasing cost and regulation in animal testing and restrictions imposed by regulatory authorities affecting antibiotic sales are expected to hamper the growth of the global market to some extent.

North America accounted for the largest share in the global market in 2015 and it is expected to grow at the considerable rate during the forecast period. The factors driving the animal pharmaceuticals market in the region are high level of urbanization, high standard of living, and high consumption of meat and milk products. Europe was the second largest market for animal pharmaceuticals devices in 2015. The European market is primarily driven by increasing awareness about the diseases associated with livestock and companion animals.

Companies Mentioned:

  • Merck & Co., Inc.
  • Vetoquinol S.A.
  • Zoetis Inc.
  • Virbac Sa
  • Boehringer Ingelheim Gmbh
  • Perrigo Company Plc
  • Eli Lilly & Company
  • Sanofi
  • Bayer Ag

Key Topics Covered:

1. Research Scope And Methodology

2. Executive Summary

3. Market Outlook

4. Animal Pharmaceuticals Market Size & Forecast (2012 - 2022)

5. Animal Pharmaceuticals Market, By Product

6. Animal Pharmaceuticals Market, By Animal Type

7. Global Animal Pharmaceuticals Market, By Geography

8. Competitive Positioning Analysis

9. Company Profiles And Strategic Developments

10. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/dspjkf/global_animal

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.